K-Ras4B/calmodulin/PI3Kα: A promising new adenocarcinoma-specific drug target?-Reference-Cited by-同舟云学术

K-Ras4B/calmodulin/PI3Kα: A promising new adenocarcinoma-specific drug target?

Published:2016-02-12 Issue:7 Volume:20 Page:831-842
ISSN:1472-8222
Container-title:Expert Opinion on Therapeutic Targets
language:en
Short-container-title:Expert Opinion on Therapeutic Targets

Author:

Nussinov Ruth¹²,Muratcioglu Serena³,Tsai Chung-Jung¹,Jang Hyunbum¹,Gursoy Attila⁴,Keskin Ozlem³

Affiliation:

1. Cancer and Inflammation Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, National Cancer Institute at Frederick, Frederick, MD, USA

2. Department of Human Molecular Genetics and Biochemistry, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel

3. Department of Chemical and Biological Engineering, Koc University, Istanbul, Turkey

4. Department of Computer Engineering, Koc University, Istanbul, Turkey

Funder

TUBITAK Research Grant

Publisher

Informa Healthcare

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1517/14728222.2016.1135131

Reference139 articles.

1. Novel Targets in Pancreatic Cancer Research

2. Targeting RAS Membrane Association: Back to the Future for Anti-RAS Drug Discovery?

3. RAS Synthetic Lethal Screens Revisited: Still Seeking the Elusive Prize?

4. Pancreatic cancer: optimizing treatment options, new, and emerging targeted therapies

5. Molecular landscape of pancreatic cancer: implications for current clinical trials

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel approaches for the development of direct KRAS inhibitors: structural insights and drug design;Expert Opinion on Drug Discovery;2022-01-27

2. Advances in Intracellular Calcium Signaling Reveal Untapped Targets for Cancer Therapy;Biomedicines;2021-08-24

3. Novel PI3K/Akt/mTOR pathway inhibitors plus radiotherapy: Strategy for non-small cell lung cancer with mutant RAS gene;Life Sciences;2020-08

4. The Structural Basis of the Farnesylated and Methylated KRas4B Interaction with Calmodulin;Structure;2019-11

5. Drugging K-RasG12C through covalent inhibitors: Mission possible?;Pharmacology & Therapeutics;2019-10